These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 7625371
1. Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy. Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Am J Clin Oncol; 1995 Aug; 18(4):303-6. PubMed ID: 7625371 [Abstract] [Full Text] [Related]
2. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study. Graziano SL, Herndon JE, Richards F, DiFino S, Modeas C, Duggan DB, Green MR. Cancer; 1993 Jul 01; 72(1):62-8. PubMed ID: 8389667 [Abstract] [Full Text] [Related]
3. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer. Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Semin Oncol; 1992 Feb 01; 19(1 Suppl 1):49-53. PubMed ID: 1329212 [Abstract] [Full Text] [Related]
4. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study. Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR. Lung Cancer; 1996 Jun 01; 14(2-3):315-29. PubMed ID: 8794413 [Abstract] [Full Text] [Related]
5. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma. Vallejo C, Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, Rodriguez R, Barbieri M, Romero Acuña L, Romero Acuña J, Langhi M, Amato S, Salvadori M, Ortiz E, Machiavelli M, Leone B. Am J Clin Oncol; 1996 Dec 01; 19(6):584-8. PubMed ID: 8931677 [Abstract] [Full Text] [Related]
6. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer. Fujita A, Takabatake H, Tagaki S, Sekine K. Cancer Chemother Pharmacol; 2000 Dec 01; 45(4):279-83. PubMed ID: 10755315 [Abstract] [Full Text] [Related]
7. A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer. Kosmas C, Tsavaris NB, Makatsoris T, Onyenadum A, Vadiaka M, Stavroyianni N, Sepsas E, Dimitropoulos D, Rokana S, Kalofonos HP. Int J Cancer; 2002 Mar 01; 98(1):141-7. PubMed ID: 11857398 [Abstract] [Full Text] [Related]
8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE. Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [Abstract] [Full Text] [Related]
9. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma. Glisson B, Lee JS, Palmer J, Fossella F, Shin DM, Murphy WK, Perez-Soler R, Hong WK. Cancer; 1998 Jan 15; 82(2):301-8. PubMed ID: 9445186 [Abstract] [Full Text] [Related]
10. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer. Evans WK, Stewart D, Logan D, Maroun J, Goss G, Shepherd FA, Latreille J, Warner E, Dahrouge S. Semin Oncol; 1992 Dec 15; 19(6 Suppl 12):51-6. PubMed ID: 1336622 [Abstract] [Full Text] [Related]
12. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer. Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB. Chest; 1999 Jan 15; 115(1):144-50. PubMed ID: 9925076 [Abstract] [Full Text] [Related]
13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. Cancer J Sci Am; 1997 Jan 15; 3(5):297-302. PubMed ID: 9327154 [Abstract] [Full Text] [Related]
14. European experience with ifosfamide in non-small cell lung cancer. Drings P. Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):22-30. PubMed ID: 2539645 [Abstract] [Full Text] [Related]
15. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer. Rosell R, Abad-Esteve A, Moreno I, Barnadas A, Carles J, Fernandez C, Ribelles N, Culubret M. Cancer; 1990 Apr 15; 65(8):1692-9. PubMed ID: 2156597 [Abstract] [Full Text] [Related]
16. Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. Planting AS, de Wit R, van der Burg ME, Stoter G, Verweij J. Ann Oncol; 1996 Dec 15; 7(10):1080-2. PubMed ID: 9037369 [Abstract] [Full Text] [Related]
19. Phase I study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in advanced non-small cell lung cancer. Fujita A, Takabatake H, Tagaki S, Sekine K. Oncology; 1999 Dec 15; 56(4):301-7. PubMed ID: 10343194 [Abstract] [Full Text] [Related]
20. Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. Chen Y, Perng RP, Yang KY, Lin WC, Wu HW, Tsai CM, Whang-Peng J. Lung Cancer; 2000 Aug 15; 29(2):139-46. PubMed ID: 10963844 [Abstract] [Full Text] [Related] Page: [Next] [New Search]